Results 91 to 100 of about 5,265,871 (311)

Precision therapies for genetic epilepsies in 2025: Promises and pitfalls

open access: yesEpilepsia Open, EarlyView.
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang   +3 more
wiley   +1 more source

Real-world evidence on tagraxofusp for blastic plasmacytoid dendritic cell neoplasm – collected cases from a single center and case reports

open access: yesFrontiers in Oncology
IntroductionBlastic plasmacytoid dendritic cell neoplasia (BPDCN) is a rare, aggressive hematologic malignancy. Until recently, the only curative treatment consisted of intensive chemotherapy, followed by hematopoietic cell transplantation (HCT) in ...
Philipp Faustmann   +7 more
doaj   +1 more source

Finver, Natalie Weinber (Box 90, Folder 15)

open access: yes, 1989
Series VIII: Audiocassettes features informal oral histories about the Hebrew Orphan Asylum and its alumni.Digital recordingDigital finding ...
Hebrew Orphan Asylum of New York
core  

Effectiveness and safety of cannabidiol in adult patients with epilepsy: A multicenter, retrospective study

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Cannabidiol (CBD) has demonstrated promising effectiveness and tolerability as adjunctive treatment in patients with severe childhood epilepsies. This study investigated the effectiveness and tolerability of CBD in adults with a history of Dravet syndrome (DS), Lennox–Gastaut syndrome (LGS), or tuberous sclerosis complex (TSC ...
Sara Sánchez‐Gamino   +7 more
wiley   +1 more source

Braff, Milton (Box 90, Folder 11)

open access: yes, 1976
Series VIII: Audiocassettes features informal oral histories about the Hebrew Orphan Asylum and its alumni.Digital recordingDigital finding ...
Hebrew Orphan Asylum of New York
core  

Next‐Generation CAR‐T Cell Therapy: From Modular Design to Clinical Expansion

open access: yesExploration, EarlyView.
Over the past decades, chimeric antigen receptor (CAR)‐T cell therapy has evolved from a linear engineering concept into a powerful yet constrained immunotherapy, limited by tumour microenvironment barriers, immune evasion, and manufacturing complexity.
Yuesong Bai   +5 more
wiley   +1 more source

Withdrawn Article

open access: yesMolecular Genetics and Metabolism Reports, 2019
This article has been withdrawn at the request of the authors(s) and/or editor. The Publisher apologizes for any inconvenience this may cause.The full article title has been removed because it contains two rare conditions that may identify the patient ...
Alcy Torres   +21 more
doaj   +1 more source

Delin, Lou (Box 90, Folder 14)

open access: yes, 1977
Series VIII: Audiocassettes features informal oral histories about the Hebrew Orphan Asylum and its alumni.Digital recordingDigital finding ...
Hebrew Orphan Asylum of New York
core  

Bioavailability through lactic fermentation in millet for combating hidden hunger

open access: yesFood Biomacromolecules, EarlyView.
Millets are nutrient‐rich grains with considerable potential to combat hidden hunger, but the presence of anti‐nutritional factors, can restrict mineral bioavailability. Processing strategies including soaking, germination, cooking, and lactic acid fermentation can reduce the anti‐nutritional factors.
Ajina Anila Sugathan   +3 more
wiley   +1 more source

Idiopathic recurrent pericarditis: Yesterday, today, and tomorrow

open access: yesТерапевтический архив
Idiopathic recurrent pericarditis (IRP) is an orphan inflammatory disease of the pericardium, characterised by the absence of pathognomonic symptoms and specific biomarkers. The diagnosis is complicated by the absence of characteristic clinical signs and
Alfiya А. Safiullina   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy